Bernardo, Janella B.

HRN: 17-91-03  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/14/2026
CEFUROXIME 1.5GM (VIAL)
02/14/2026
02/20/2026
IV
500mg
Q8hours
PCAP-C
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: